Inhibition of interleukin‐1 with rilonacept is not effective in cold urticaria—Results of a randomized, placebo‐controlled study

BACKGROUND: Cold urticaria (ColdU) is characterized by pruritic wheals following exposure of the skin to cold. Many patients show insufficient response to antihistamines, the first line treatment. Based on the high efficacy of interleukin‐1(IL‐1)‐inhibition in cold‐induced urticarial autoinflammator...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonnekoh, Hanna, Butze, Monique, Spittler, Sebastian, Staubach, Petra, Weller, Karsten, Scheffel, Jörg, Maurer, Marcus, Krause, Karoline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9975456/
https://www.ncbi.nlm.nih.gov/pubmed/36973954
http://dx.doi.org/10.1002/clt2.12226

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9975456/
https://www.ncbi.nlm.nih.gov/pubmed/36973954
http://dx.doi.org/10.1002/clt2.12226

Ejemplares similares